trending Market Intelligence /marketintelligence/en/news-insights/trending/gcbz60PeLZJ6bDuklKQgWw2 content esgSubNav
In This List

Dermira plans $110M common stock offering

Video

S&P Capital IQ Pro | Unrivaled Sector Coverage

Video

S&P Capital IQ Pro | Powering Your Edge

Blog

Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud

Blog

Investment Research Analysts Providing Greater Coverage on Inflation


Dermira plans $110M common stock offering

Dermira Inc. plans to sell $110 million of its common shares in an underwritten public offering.

The biopharmaceutical company plans to grant the underwriters an option to buy up to an additional $16.5 million of its common stock in the offering.

Citigroup, Cowen, Cantor Fitzgerald & Co. and Guggenheim Securities are acting as book-runners, with Needham & Co. and H.C. Wainwright & Co. as co-managers.

Menlo Park, Calif.-based Dermira develops and commercializes therapies for patients with skin conditions. The company offers Qbrexza for the treatment of primary axillary hyperhidrosis — a certain condition in which excessive sweating occurs — in adults and pediatric patients nine years and older.